Funding for this research was provided by:
Daiichi Sankyo Europe GmbH, Munich, Germany
Text and Data Mining valid from 2018-05-01
Received: 16 December 2017
Accepted: 6 February 2018
First Online: 1 May 2018
Change Date: 6 June 2018
Change Type: Correction
Change Details: Correction to: Thrombosis Journal (2018) 16:9 DOI 10.1186/s12959-018-0163-7
Ethics approval and consent to participate
: Approval from the responsible ethics committees and institutional review boards will be obtained prior to protocol implementation. Informed consent will be obtained from all patients prior to enrolment and compliance with the Declaration of Helsinki will be ensured throughout the study.
: Not applicable.
: The members of the Steering Committee received honoraria for their advice in the planning of the Registry. They also received honoraria and travel reimbursements from Daiichi Sankyo Europe GmbH for their participation in Steering Committee Meetings.Alexander T. Cohen, Hervé Décousus, Pedro Marques da Silva, David Jimenez Castro, Beatrice Amann-Vesti, Bernd Brüggenjürgen, Eric Vicaut and Giancarlo Agnelli have received research support and/or honoraria for lectures from a number of pharmaceutical companies including Daiichi Sankyo, the sponsor of the registry.Cihan Ay received honoraria for lectures from Sanofi, Pfizer/BMS, Daiichi-Sankyo, Boehringer Ingelheim, and Bayer. Advisory board membership for Pfizer/BMS, Daiichi-Sankyo, Boehringer Ingelheim, and Bayer.Philippe Hainaut received honoraria from Daiichi Sankyo Europe GmbH for lectures and advisory board membership.Ulrich Hoffmann received honoraria for lectures from Bayer, Daiichi-Sankyo, Leo Pharma, Pfizer, Bristol-Meyers, Aspen, Sanofi-Aventis, Amgen. Advisory board membership for Bayer, Daiichi-Sankyo, Leo Pharma, Sanofi-Aventis, and Amgen.Sean Gaine received honoraria for lectures from Actelion Pharmaceuticals Ltd., Bayer, GlaxoSmithKline, Merck Sharpe & Dohme, and has received advisory and/or drug safety board fees from Astra Zeneca, Actelion Pharmaceuticals Ltd., Bayer, GlaxoSmithKline, Novartis, Pfizer and Daiichi-Sankyo, Menerini, and United Therapeutics.Michiel Coppens has received research funding and honoraria for consultancy or lecturing from Daiichi Sankyo, Boehringer Ingelheim, Bayer, Bristol-Myers Squibb and Pfizer.Pierre Levy received honoraria for lectures from AbbVie, Amgen, Gilead, GSK, Novo Nordisk, ViiV. Advisory board membership for AbbVie, Actelion, Amgen, Astellas, Bayer, Biogen, Boehringer Ingelheim, Celgène, Daiichi Sankyo, Eli Lilly, EOS, GSK, Janssen, MSD, Mundipharma, Novartis, Pfizer, Roche, Shire, Vertex.Julio Lopez Bastida received honoraria from Daiichi Sankyo.Petra Laeis, Eva-Maria Fronk, Wolfgang Zierhut, and Thomas Malzer are employees of Daiichi Sankyo Europe GmbH.Peter Bramlage received research funding and consultancy honoraria from Daiichi Sankyo Europe GmbH. He further received funding for drafting the manuscript.The members of the Steering Committee received honoraria and travel reimbursements from Daiichi Sankyo Europe GmbH for their participation in Steering Committee Meetings.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.